CONDUIT PHARMACEUTICALS INC.·4

Nov 20, 4:30 PM ET

Lewis-Hall Freda C 4

4 · CONDUIT PHARMACEUTICALS INC. · Filed Nov 20, 2024

Insider Transaction Report

Form 4
Period: 2024-11-18
Transactions
  • Award

    Common Stock

    2024-11-18$0.09/sh+437,976$40,250437,976 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,003,324
  • Common Stock

    (indirect: See Footnote)
    516,987
Footnotes (3)
  • [F1]Represents shares issued in lieu of $40,250 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program.
  • [F2]The shares are held of record by Intelmed LLC ("Intelmed"). Ms. Lewis-Hall is the Managing Director of Intelmed and in such capacity has voting and investment discretion with respect to the Shares held of record by Intelmed. By virtue of this relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of the shares held of record by Intelmed. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein.
  • [F3]The shares are held by Ms. Lewis-Hall's spouse, Mr. Emerson Hall, Jr. As Mr. Hall's spouse and by virtue of their relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of such shares held by record by Mr. Emerson Hall, Jr. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein.

Documents

1 file
  • 4
    ownership.xmlPrimary